Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages
Pennsylvania Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center A Pennsylvania Collateral License Agreement is a legal document outlining the terms and conditions of the licensing agreement between Gentling, Inc. and The University of North Texas Health Science Center. This agreement allows Gentling, Inc. to utilize certain intellectual property rights, inventions, and patents owned by The University of North Texas Health Science Center for designated purposes within the state of Pennsylvania. This agreement aims to promote collaboration and the commercialization of research and development efforts between Gentling, Inc. and The University of North Texas Health Science Center. It establishes the rights and responsibilities of both parties, ensuring that the licensed technologies are used appropriately and for the mutual benefit of the two entities. Some key elements and provisions that may be included in a Pennsylvania Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center are: 1. Scope of License: Clearly define the specific technologies, intellectual property, or patents covered by the agreement. This may include gene therapy techniques, genetic testing methodologies, or DNA-based diagnostic tools, among other relevant technologies. 2. Territory: Specify that the license is limited to the state of Pennsylvania, ensuring that Gentling, Inc. can only exercise the granted rights within this geographical region. 3. Term and Renewal: Establish the duration of the agreement and outline the conditions for renewal or termination. This allows both parties to reassess the collaboration periodically and make necessary adjustments based on changing circumstances. 4. Royalties and Financial Considerations: Address the financial arrangements, including licensing fees, royalties, and any potential revenue sharing. This section ensures that both parties benefit from the commercialization of licensed technologies. 5. Patent Prosecution and Defense: Outline the responsibilities of each party regarding the filing, prosecution, maintenance, and defense of relevant patents. This ensures that the licensed technologies are protected and that both parties actively contribute to their enforcement. 6. Confidentiality and Data Sharing: Establish guidelines and obligations regarding the protection and sharing of confidential information or research data. This promotes trust and collaboration while protecting proprietary information. It is important to note that the specific terms and provisions of a Pennsylvania Collateral License Agreement may vary depending on the nature of the licensed technologies and the strategic goals of both Gentling, Inc. and The University of North Texas Health Science Center. While there may not be different types of Pennsylvania Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center, there may be variations in the content and terms based on the specific technologies or patents being licensed.
Pennsylvania Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center A Pennsylvania Collateral License Agreement is a legal document outlining the terms and conditions of the licensing agreement between Gentling, Inc. and The University of North Texas Health Science Center. This agreement allows Gentling, Inc. to utilize certain intellectual property rights, inventions, and patents owned by The University of North Texas Health Science Center for designated purposes within the state of Pennsylvania. This agreement aims to promote collaboration and the commercialization of research and development efforts between Gentling, Inc. and The University of North Texas Health Science Center. It establishes the rights and responsibilities of both parties, ensuring that the licensed technologies are used appropriately and for the mutual benefit of the two entities. Some key elements and provisions that may be included in a Pennsylvania Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center are: 1. Scope of License: Clearly define the specific technologies, intellectual property, or patents covered by the agreement. This may include gene therapy techniques, genetic testing methodologies, or DNA-based diagnostic tools, among other relevant technologies. 2. Territory: Specify that the license is limited to the state of Pennsylvania, ensuring that Gentling, Inc. can only exercise the granted rights within this geographical region. 3. Term and Renewal: Establish the duration of the agreement and outline the conditions for renewal or termination. This allows both parties to reassess the collaboration periodically and make necessary adjustments based on changing circumstances. 4. Royalties and Financial Considerations: Address the financial arrangements, including licensing fees, royalties, and any potential revenue sharing. This section ensures that both parties benefit from the commercialization of licensed technologies. 5. Patent Prosecution and Defense: Outline the responsibilities of each party regarding the filing, prosecution, maintenance, and defense of relevant patents. This ensures that the licensed technologies are protected and that both parties actively contribute to their enforcement. 6. Confidentiality and Data Sharing: Establish guidelines and obligations regarding the protection and sharing of confidential information or research data. This promotes trust and collaboration while protecting proprietary information. It is important to note that the specific terms and provisions of a Pennsylvania Collateral License Agreement may vary depending on the nature of the licensed technologies and the strategic goals of both Gentling, Inc. and The University of North Texas Health Science Center. While there may not be different types of Pennsylvania Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center, there may be variations in the content and terms based on the specific technologies or patents being licensed.